About Submental fullness (double chin)
Submental fullness, sometimes referred to as “double chin”, is a common yet undertreated facial aesthetic condition. It can impact a broad range of adults, including both men and women, and can be influenced by several factors such as:
If you’re bothered by submental fullness, you’re not alone. According to a 2014 survey conducted by the American Society for Dermatologic Surgery (ASDS):
What is Kybella™?
KYBELLA™ is the first and only FDA-approved nonsurgical treatment that contours and improves the appearance of submental fullness.
How Kybella™ works
The active ingredient in KYBELLA™ is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
When injected into the fat beneath your chin, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
You and your doctor will decide how many treatments you need. Once the desired aesthetic response is achieved with KYBELLA™, retreatment is not expected.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Especially tell your healthcare provider if you take a medicine that prevents the clotting of your blood (antiplatelet or anticoagulant medicine).
What to Expect
KYBELLA™ (deoxycholic acid) injection is the first and only FDA-approved nonsurgical treatment that contours and improves the appearance of submental fullness, sometimes referred to as “double chin”.
You and your doctor will design a customized treatment plan to help you improve your chin profile. Many patients experience visible contouring of their chin profile in two to four treatment sessions spaced at least one month apart. Up to 6 treatments may be administered.
KYBELLA™ has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with KYBELLA™.
In the pivotal Phase III clinical trials:
KYBELLA™ is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called, “double chin.” It is not known if KYBELLA™ is safe and effective in children less than 18 years of age. It is not known if KYBELLA™ is safe and effective for use outside of the submental area.
Unretouched photos of clinical trial patient taken before and after 4 treatment sessions with KYBELLA™. Individual results may vary.
Weight (before): 115.5 lbs
Weight (after): 113.2 lbs
Unretouched photos of clinical trial patient taken before and after 3 treatment sessions with KYBELLA™. Individual results may vary.
Weight (before): 125.0 lbs
Weight (after): 130.0 lbs
For more information visit: consumers.mykybella.com